Investing in Innovation Africa (i3), a pan-African initiative supporting healthtech startups to scale and commercialize, is accepting applications for its 3rd cohort until February 28th.
The details
- What’s offered: Selected startups will receive flexible grants, tailored mentorship, and introductions to potential customers to secure partnerships.
- Early-stage startups will receive $50K each.
- Growth-stage startups focused on pharmacy care will receive $225K each.
- Impact goals: i3 aims to facilitate 150 connections between startups and healthcare organizations, worth at least $30M, to improve patient access and create local jobs.
- Eligibility: The cohort will include 15 startups: 10 early-stage innovators in healthcare delivery or product distribution, and 5 growth-stage ventures building pharmacy care solutions.
Why it matters
In two years, i3 has empowered 60 startups across 16 African countries, distributing $3M in grants, enabling $11M+ in contracted partnerships, and creating nearly 1,000 jobs—half held by women.
What they’re saying
- Dr. Uchenna Igbokwe, CEO, SCIDaR: “i3 proves that with the right resources, African-led companies can scale while reaching underserved communities and creating jobs.”
- Oghenetega Iortim, CEO of Figorr and i3 alumni: “Through i3, we connected with major global customers, expanding our impact in Nigeria and beyond.”
What’s next
- Applications close on February 28th: Apply here.
- A virtual Q&A session on February 21st will address application questions.
- Selected startups will be announced on April 30th.
The initiative is coordinated by Salient Advisory and SCIDaR, with cohort selection led by CcHUB, Villgro Africa, and African experts.
